Results 141 to 150 of about 2,386 (174)

Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis

Journal of the Neurological Sciences, 1993
We studied the effects of LDL-apheresis on the biochemical and clinical abnormalities of 5 patients with cerebrotendinous xanthomatosis (CTX). Levels of both cholestanol and cholesterol decreased to approximately 60% of those of pretreatment after one perfusion and gradually returned to their initial levels within 2 weeks.
Y, Mimura, M, Kuriyama, Y, Tokimura, J, Fujiyama, M, Osame, K, Takesako, N, Tanaka   +6 more
openaire   +2 more sources

Low-Density Lipoprotein (LDL) Apheresis

2015
Low-density lipoprotein (LDL) apheresis, also referred to as lipoprotein apheresis or lipid apheresis, is a procedure that involves extracorporeal treatment of plasma to remove apoprotein (apo) B-containing lipoproteins followed by reinfusion of the processed blood.
openaire   +1 more source

Effect of low-density lipoprotein cholesterol apheresis on blood viscosity

The American Journal of Cardiology, 2004
Few studies have been designed to study the hemodynamic effects of low-density lipoprotein apheresis, especially on whole blood viscosity. Six patients with cardiovascular disease and hypercholesterolemia underwent a single low-density lipoprotein apheresis, resulting in significant reductions in whole blood viscosity at all shear rates.
Patrick M, Moriarty, Cheryl A, Gibson, Kenneth R, Kensey, William, Hogenauer   +3 more
openaire   +2 more sources

Low‐Density Lipoprotein Apheresis and Regression of Atherosclerotic Plaque In Vitro

Artificial Organs, 1986
Abstract: Short‐term organ culture and primary cell culture of human aorta were used to study the effect of selective removal of low‐density lipoproteins (LDLs) from the surrounding medium (LDL apheresis) on the lipid content of cultured tissue and cells, respectively.
A N, Orekhov, K A, Khashimov, D N, Mukhin, V V, Tertov, , Adamova IYu, S N, Pokrovsky, V N, Smirnov   +6 more
openaire   +2 more sources

Selective and Semiselective Low-Density Lipoprotein Apheresis in Familial Hypercholesterolemia

Blood Purification, 2008
Seven patients with familial hypercholesterolemia were treated fortnightly for 3 months by selective low-density lipoprotein apheresis with dextran-sulfate cellulose column (DSC). Subsequently, 4 of them were treated with semiselective double filtration. No cholesterol-lowering drugs were given.
G, Busnach, A, Cappelleri, V, Vaccarino, G, Franceschini, A, Dal Col, M L, Perrino, B, Brando, C, Sirtori, L, Minetti   +8 more
openaire   +2 more sources

Is Low Density Lipoprotein Apheresis Effective for Coronary Artery Disease?

ASAIO Journal, 1998
Low density lipoprotein (LDL) apheresis is one type of therapy currently being used for coronary artery disease; however, there has been no study to compare the effectiveness of this therapy with the effectiveness of other treatments, such as coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA). In this study,
Y, Kutsumi, H, Tada, A, Iwamuro, H, Kabuto   +3 more
openaire   +2 more sources

Assessment of Currently Available Low‐Density Lipoprotein Apheresis Systems

Artificial Organs, 1994
Abstract: It has already been 10 years since the introduction of low‐density lipoprotein (LDL) apheresis technologies. They have been established as technically and medically feasible for long‐term treatment and economically acceptable, and their long‐term treatment effects have been determined.
Y, Matsuda, P S, Malchesky, Y, Nosé
openaire   +2 more sources

Low‐density Lipoprotein Apheresis in the Treatment of Peripheral Arterial Disease

Therapeutic Apheresis and Dialysis, 2003
Abstract:  Low‐density lipoprotein (LDL) apheresis is performed in patients with homozygous familial hyper‐cholesterolemia who lack LDL receptors and with heterozygous familial hypercholesterolemia who are LDL receptor deficient with documented, symptomatic coronary artery disease who are resistant to diet changes and maximum drug therapy.
openaire   +2 more sources

Low-density-lipoprotein apheresis

The Lancet, 1995
C.J. Olbricht, WernerO. Richter, Peter Schwandt, GilbertR. Thompson, IonS. Jovin, Uwe Taborski, Kathrin Heidinger, Gert Müller-Berghaus   +7 more
openaire   +1 more source

The Current Status of Low-Density Lipoprotein Apheresis

2015
H, Borberg, J, Kadar, K, Oette
openaire   +2 more sources